Dr. Hans Klingemann, pioneering immunotherapy scientist, has studied whether the innovative treatment could save his two pets.
ยฉ Matt Cosby for The New York Times
Dr. Hans Klingemann is the chief science officer at ImmunityBio, which develops immunotherapy drugs for people. He also explores whether the treatments might someday prolong dogsโ lives.